Rosh Dias
Chief Tech/Sci/R&D Officer at COHERUS BIOSCIENCES, INC.
Profile
Rosh Dias currently works at The Royal College of Physicians, as Member and Coherus BioSciences, Inc., as Chief Medical Officer from 2022.
Mr. Dias also formerly worked at Aventis Pharmaceuticals, Inc., as Global Medical Director-Oncology, Amgen, Inc., as Vice President-Global Scientific Affairs from 2015 to 2018, Onyx Pharmaceuticals, Inc., as VP, Head-Global Medical & Scientific Affairs from 2014 to 2015, Novartis International AG, as Vice President-Oncology Scientific Operations from 2004 to 2014, Indivior PLC, as Chief Medical Officer from 2019 to 2020, Novartis Australia Pty Ltd., as Head-Clinical Development & Medical Affairs from 2004 to 2014, and Spruce Biosciences, Inc., as Chief Medical Officer.
Mr. Dias received his graduate degree from The Royal College of Physicians and graduate degree from Charing Cross Hospital Medical School.
Rosh Dias active positions
Companies | Position | Start |
---|---|---|
COHERUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-03-14 |
The Royal College of Physicians | Corporate Officer/Principal | - |
Former positions of Rosh Dias
Companies | Position | End |
---|---|---|
SPRUCE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-03-13 |
INDIVIOR PLC | Chief Tech/Sci/R&D Officer | 2020-07-31 |
AMGEN INC. | Chief Tech/Sci/R&D Officer | 2017-12-31 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Chief Tech/Sci/R&D Officer | 2015-02-28 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 2013-12-31 |
Training of Rosh Dias
The Royal College of Physicians | Graduate Degree |
Charing Cross Hospital Medical School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
INDIVIOR PLC | Health Technology |
SPRUCE BIOSCIENCES, INC. | Health Technology |
AMGEN INC. | Health Technology |
COHERUS BIOSCIENCES, INC. | Health Technology |
Private companies | 4 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Health Technology |
- Stock Market
- Insiders
- Rosh Dias